Quick Takeaways
- GILD - GILEAD SCIENCES, INC. has 22 insiders with reported activity on this page.
- Net insider value flow over the last year: -$76,176,203.
- Recent transaction rows are available for direct filing-level review.
- Info
- Portfolio
- Significant Ownership
- Insider Ownership
- Insider Trading
- Financials
- Holders
Insider Transactions Reported by 22 Insiders of GILEAD SCIENCES, INC.
- Symbol
- GILD on Nasdaq
- Location
- Foster City, CA
What Changed
- Buy value: ; sell value: $76,176,203.
- Net share flow: -580,537.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Official SEC Source
Insider trading overview
Last 12 monthsNet insider flow leans to selling over the last 12 months. Net value: -$76,176,203.
Buys
$0
Shares: 0
Insiders: 0
Sells
$76,176,203
Shares: 580,537
Insiders: 6
Net
-$76,176,203
Shares: -580,537
Insiders: -6
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 309,280 | $0 | $44,188,590 | -$44,188,590 |
| 3-6 | 0 | 136,257 | $0 | $16,855,403 | -$16,855,403 |
| 6-9 | 0 | 76,500 | $0 | $8,791,485 | -$8,791,485 |
| 9-12 | 0 | 58,500 | $0 | $6,340,725 | -$6,340,725 |
GILEAD SCIENCES, INC. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Daniel Patrick O'Day | Chairman & CEO, Director | $101,902,354 | -$46,480,883 | -31% | Mixed | 27 Mar 2026 |
| Andrew D. Dickinson | Chief Financial Officer | $30,370,078 | -$3,891,985 | -11% | Mixed | 16 Mar 2026 |
| Johanna Mercier | Chief Comm & Corp Aff Officer | $23,601,469 | -$16,708,062 | -41% | Mixed | 16 Mar 2026 |
| Merdad Parsey | Chief Medical Officer | $13,940,850 | Mixed | 10 Dec 2024 | ||
| Deborah H. Telman | EVP, Corporate Affairs & GC | $9,143,992 | -$6,590,487 | -42% | Mixed | 12 Nov 2025 |
| Dietmar Berger | Chief Medical Officer | $8,821,036 | Mixed | 10 Mar 2026 | ||
| Olsen Per Wold | Director | $8,754,707 | Mixed | 06 May 2021 | ||
| Sandra C. Patterson | SVP, Controllership | $6,811,146 | Mixed | 10 Mar 2025 | ||
| Diane E. Wilfong | Interim Corp Controller & CAO | $5,331,349 | Mixed | 10 Sep 2025 | ||
| Brett A. Pletcher | EVP,Corp Affairs & Gen Counsel | $4,172,613 | Mixed | 10 Jun 2022 | ||
| Richard James Whitley | Director | $3,154,008 | Mixed | 06 May 2021 | ||
| Jacqueline K. Barton | Director | $2,700,183 | Mixed | 07 May 2025 | ||
| Harish Manwani | Director | $1,393,797 | Mixed | 07 May 2025 | ||
| Javier Rodriguez | Director | $1,266,151 | Mixed | 07 May 2025 | ||
| Anthony S. Welters | Director | $1,217,445 | Mixed | 07 May 2025 | ||
| Jeffrey A. Bluestone | Director | $1,101,620 | -$1,791,600 | -62% | Filing P/S | 20 Jan 2026 |
| Sandra Horning | Director | $1,042,554 | Mixed | 07 May 2025 | ||
| Keeley M. Cain Wettan | EVP Gen Counsel, Legal & Comp | $754,915 | Mixed | 10 Mar 2026 | ||
| Ted W. Love | Director | $449,546 | Mixed | 07 May 2025 | ||
| Kelly A. Kramer | Director | $170,186 | -$713,186 | -81% | Filing P/S | 26 Nov 2025 |
| Erin E. Burkhart | SVP, Controllership | Mixed | 10 Mar 2026 | |||
| Kevin E. Lofton | Director | Mixed | 28 Mar 2024 |
Top shareholders of GILEAD SCIENCES, INC. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
8.2%
from 13D/G
|
123,195,578
|
$15,121,025,249 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.8%
|
121,097,336
|
$14,863,487,020 | — | 31 Dec 2025 | |
| FMR LLC |
13F
13D/G
|
Company |
5.3%
from 13D/G
|
65,579,490
|
$8,049,226,574 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
4.9%
|
60,240,518
|
$7,393,921,179 | — | 31 Dec 2025 | |
| Capital World Investors |
13D/G
13F
|
Company |
4.3%
|
53,834,873
|
$5,714,571,769 | $0 | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
29,696,002
|
$3,637,368,762 | — | 31 Dec 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.2%
|
27,698,660
|
$3,399,734,000 | — | 31 Dec 2025 | |
| DODGE & COX |
13F
|
Company |
2.1%
|
26,283,511
|
$3,226,038,140 | — | 31 Dec 2025 | |
| Capital Research Global Investors |
13F
|
Company |
2%
|
25,307,071
|
$3,106,193,871 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.9%
|
23,512,734
|
$2,885,953,592 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.9%
|
23,121,620
|
$2,837,947,589 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.9%
|
23,035,763
|
$2,827,409,785 | — | 31 Dec 2025 | |
| NORGES BANK |
13F
|
Company |
1.7%
|
21,322,732
|
$2,617,152,126 | — | 31 Dec 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.3%
|
15,907,304
|
$1,952,462,494 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
1.3%
|
15,584,341
|
$1,912,822,026 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.2%
|
15,215,384
|
$1,867,536,232 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.1%
|
14,057,956
|
$1,725,473,519 | — | 31 Dec 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
1.1%
|
13,000,814
|
$1,595,719,911 | — | 31 Dec 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.83%
|
10,317,613
|
$1,266,383,821 | — | 31 Dec 2025 | |
| Amundi |
13F
|
Individual |
0.77%
|
9,520,135
|
$1,168,501,370 | — | 31 Dec 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.74%
|
9,115,483
|
$1,118,834,386 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.72%
|
8,846,313
|
$1,085,839,581 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.71%
|
8,752,513
|
$1,074,283,499 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.65%
|
8,006,790
|
$982,753,405 | — | 31 Dec 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.63%
|
7,800,418
|
$957,455,907 | — | 31 Dec 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.54%
|
6,649,175
|
$816,119,673 | — | 31 Dec 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.51%
|
6,314,056
|
$774,987,233 | — | 31 Dec 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.5%
|
6,193,754
|
$760,221,365 | — | 31 Dec 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.48%
|
5,912,881
|
$725,747,000 | — | 31 Dec 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.48%
|
5,896,300
|
$723,711,862 | — | 31 Dec 2025 | |
| NORDEA INVESTMENT MANAGEMENT AB |
13F
|
Company |
0.42%
|
5,138,699
|
$630,055,884 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.39%
|
4,779,679
|
$586,657,800 | — | 31 Dec 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.35%
|
4,293,884
|
$527,031,420 | — | 31 Dec 2025 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.34%
|
4,223,304
|
$518,368,332 | — | 31 Dec 2025 | |
| Boston Partners |
13F
|
Company |
0.34%
|
4,220,501
|
$517,808,259 | — | 31 Dec 2025 | |
| Holocene Advisors, LP |
13F
|
Company |
0.34%
|
4,164,438
|
$511,143,120 | — | 31 Dec 2025 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
0.34%
|
4,146,280
|
$508,914,000 | — | 31 Dec 2025 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.33%
|
4,030,530
|
$494,707,252 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.31%
|
3,887,520
|
$477,154,205 | — | 31 Dec 2025 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.31%
|
3,775,156
|
$463,555,279 | — | 31 Dec 2025 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.3%
|
3,701,656
|
$454,341,257 | — | 31 Dec 2025 | |
| Robeco Institutional Asset Management B.V. |
13F
|
Company |
0.3%
|
3,693,602
|
$453,352,712 | — | 31 Dec 2025 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.3%
|
3,672,001
|
$450,767,000 | — | 31 Dec 2025 | |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. |
13F
|
Company |
0.29%
|
3,559,632
|
$436,909,000 | — | 31 Dec 2025 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.28%
|
3,468,794
|
$425,759,793 | — | 31 Dec 2025 | |
| Swiss National Bank |
13F
|
Company |
0.27%
|
3,400,200
|
$417,340,548 | — | 31 Dec 2025 | |
| Pacer Advisors, Inc. |
13F
|
Company |
0.27%
|
3,381,809
|
$415,083,237 | — | 31 Dec 2025 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.27%
|
3,357,740
|
$412,129,007 | — | 31 Dec 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.27%
|
3,295,546
|
$404,494,739 | — | 31 Dec 2025 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.26%
|
3,269,117
|
$401,251,421 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for GILEAD SCIENCES, INC.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Daniel Patrick O'Day | GILD | Common Stock | Sale | -1.53% | $1,368,162 | $136.82 | -10,000 | 642,567 | 27 Mar 2026 | Direct |
| Johanna Mercier | GILD | Common Stock | Sale | -2.23% | $432,690 | $144.23 | -3,000 | 131,779 | 16 Mar 2026 | Direct |
| Andrew D. Dickinson | GILD | Common Stock | Sale | -1.65% | $432,690 | $144.23 | -3,000 | 179,191 | 16 Mar 2026 | Direct |
| Andrew D. Dickinson | GILD | Common Stock | Tax liability | -1.7% | -3,147 | 182,191 | 10 Mar 2026 | Direct | ||
| Andrew D. Dickinson | GILD | Common Stock | Options Exercise | 3.62% | 6,469 | 185,338 | 10 Mar 2026 | Direct | ||
| Andrew D. Dickinson | GILD | Non-qualified Stock Option (Right to Buy) | Award | 35,880 | 35,880 | 10 Mar 2026 | Direct | |||
| Andrew D. Dickinson | GILD | Restricted Stock Unit | Award | 45.5% | 9,590 | 30,647 | 10 Mar 2026 | Direct | ||
| Andrew D. Dickinson | GILD | Restricted Stock Unit | Options Exercise | -23.5% | -6,469 | 21,057 | 10 Mar 2026 | Direct | ||
| Johanna Mercier | GILD | Common Stock | Tax liability | -2.33% | -3,216 | 134,779 | 10 Mar 2026 | Direct | ||
| Johanna Mercier | GILD | Common Stock | Options Exercise | 5.04% | 6,617 | 137,995 | 10 Mar 2026 | Direct | ||
| Johanna Mercier | GILD | Non-qualified Stock Option (Right to Buy) | Award | 35,880 | 35,880 | 10 Mar 2026 | Direct | |||
| Johanna Mercier | GILD | Restricted Stock Unit | Award | 45.5% | 9,590 | 30,647 | 10 Mar 2026 | Direct | ||
| Johanna Mercier | GILD | Restricted Stock Unit | Options Exercise | -23.9% | -6,617 | 21,057 | 10 Mar 2026 | Direct | ||
| Keeley M. Cain Wettan | GILD | Common Stock | Tax liability | -10.7% | -606 | 5,054 | 10 Mar 2026 | Direct | ||
| Keeley M. Cain Wettan | GILD | Common Stock | Options Exercise | 28.2% | 1,246 | 5,660 | 10 Mar 2026 | Direct | ||
| Keeley M. Cain Wettan | GILD | Non-qualified Stock Option (Right to Buy) | Award | 18,885 | 18,885 | 10 Mar 2026 | Direct | |||
| Keeley M. Cain Wettan | GILD | Restricted Stock Unit | Award | 32.5% | 5,050 | 20,586 | 10 Mar 2026 | Direct | ||
| Keeley M. Cain Wettan | GILD | Restricted Stock Unit | Options Exercise | -7.42% | -1,246 | 15,536 | 10 Mar 2026 | Direct | ||
| Erin E. Burkhart | GILD | Non-qualified Stock Option (Right to Buy) | Award | 5,455 | 5,455 | 10 Mar 2026 | Direct | |||
| Erin E. Burkhart | GILD | Restricted Stock Unit | Award | 26.5% | 2,355 | 11,245 | 10 Mar 2026 | Direct | ||
| Daniel Patrick O'Day | GILD | Common Stock | Tax liability | -1.47% | -9,767 | 652,567 | 10 Mar 2026 | Direct | ||
| Daniel Patrick O'Day | GILD | Common Stock | Options Exercise | 3.12% | 20,026 | 662,334 | 10 Mar 2026 | Direct | ||
| Daniel Patrick O'Day | GILD | Non-qualified Stock Option (Right to Buy) | Award | 122,755 | 122,755 | 10 Mar 2026 | Direct | |||
| Daniel Patrick O'Day | GILD | Restricted Stock Unit | Award | 48.2% | 32,815 | 100,859 | 10 Mar 2026 | Direct | ||
| Daniel Patrick O'Day | GILD | Restricted Stock Unit | Options Exercise | -22.7% | -20,026 | 68,044 | 10 Mar 2026 | Direct | ||
| Dietmar Berger | GILD | Common Stock | Tax liability | -5.3% | -1,063 | 18,982 | 10 Mar 2026 | Direct | ||
| Dietmar Berger | GILD | Common Stock | Options Exercise | 11.9% | 2,133 | 20,045 | 10 Mar 2026 | Direct | ||
| Dietmar Berger | GILD | Non-qualified Stock Option (Right to Buy) | Award | 31,475 | 31,475 | 10 Mar 2026 | Direct | |||
| Dietmar Berger | GILD | Restricted Stock Unit | Award | 21.6% | 8,415 | 47,461 | 10 Mar 2026 | Direct | ||
| Dietmar Berger | GILD | Restricted Stock Unit | Options Exercise | -5.18% | -2,133 | 39,046 | 10 Mar 2026 | Direct | ||
| Andrew D. Dickinson | GILD | Common Stock | Award | 6.61% | 11,090 | 178,869 | 27 Feb 2026 | Direct | ||
| Johanna Mercier | GILD | Common Stock | Award | 9.22% | 11,090 | 131,378 | 27 Feb 2026 | Direct | ||
| Dietmar Berger | GILD | Common Stock | Award | 90.9% | 8,530 | 17,912 | 27 Feb 2026 | Direct | ||
| Keeley M. Cain Wettan | GILD | Common Stock | Award | 11.9% | 470 | 4,414 | 27 Feb 2026 | Direct | ||
| Daniel P. O'Day | GILD | Common Stock | Sale | -1.53% | $1,447,859 | $144.79 | -10,000 | 642,308 | 27 Feb 2026 | Direct |
| Daniel P. O'Day | GILD | Common Stock | Award | 6.25% | 38,396 | 652,308 | 27 Feb 2026 | Direct | ||
| Johanna Mercier | GILD | Common Stock | Sale | -18.9% | $4,324,228 | $154.44 | -28,000 | 120,288 | 17 Feb 2026 | Direct |
| Johanna Mercier | GILD | Common Stock | Options Exercise | 20.3% | 25,000 | 148,288 | 17 Feb 2026 | Direct | ||
| Johanna Mercier | GILD | Non-qualified Stock Option (Right to Buy) | Options Exercise | -34.2% | -25,000 | 48,110 | 17 Feb 2026 | Direct | ||
| Andrew D. Dickinson | GILD | Common Stock | Sale | -1.76% | $463,290 | $154.43 | -3,000 | 167,779 | 17 Feb 2026 | Direct |
| Daniel P. O'Day | GILD | Common Stock | Sale | -15.8% | $17,346,000 | $150.00 | -115,640 | 613,912 | 05 Feb 2026 | Direct |
| Daniel P. O'Day | GILD | Common Stock | Options Exercise | 18.8% | 115,640 | 729,552 | 05 Feb 2026 | Direct | ||
| Daniel P. O'Day | GILD | Non-qualified Stock Option (Right to Buy) | Options Exercise | -100% | -115,640 | 0 | 05 Feb 2026 | Direct | ||
| Johanna Mercier | GILD | Common Stock | Tax liability | -16.8% | -24,800 | 123,288 | 03 Feb 2026 | Direct | ||
| Johanna Mercier | GILD | Common Stock | Award | 43.5% | 44,867 | 148,088 | 03 Feb 2026 | Direct | ||
| Daniel P. O'Day | GILD | Common Stock | Tax liability | -10.8% | -74,461 | 613,912 | 03 Feb 2026 | Direct | ||
| Daniel P. O'Day | GILD | Common Stock | Award | 23.6% | 131,675 | 688,373 | 03 Feb 2026 | Direct | ||
| Andrew D. Dickinson | GILD | Common Stock | Tax liability | -12.7% | -24,802 | 170,568 | 03 Feb 2026 | Direct | ||
| Andrew D. Dickinson | GILD | Common Stock | Award | 29.8% | 44,867 | 195,370 | 03 Feb 2026 | Direct | ||
| Daniel P. O'Day | GILD | Common Stock | Sale | -1.76% | $1,398,911 | $139.89 | -10,000 | 556,698 | 28 Jan 2026 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.